🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareWELCOME: Introduce yourself & read the community guidelines Page 8

WELCOME: Introduce yourself & read the community guidelines

Admin Mon, Feb 19, 2024 at 5:20 PM 185 replies 24,631 viewsPage 8 of 20
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Aug 10, 2024 at 1:03 AM#36
hank_denver said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Last edited: Aug 10, 2024 at 4:03 AM
34 7NeuroNate, JessicaH_TX, KevinCompounds and 31 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Aug 19, 2024 at 7:33 PM#37
hank_denver said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Agreeing with hank_denver, and the qualification matters more than the agreement. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

Last edited: Aug 20, 2024 at 12:33 AM
35 8TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 32 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Aug 29, 2024 at 1:58 PM#38
hank_denver said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Genuinely useful, thank you. I had the facts and not the framework. Taking it to my next appointment.

36 9tane_welly, Dr.PathRoch, mona_PHX and 33 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Sep 8, 2024 at 8:17 AM#39

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

37 10mike.trainer_LA, sarah_nash92, FitDadDave and 34 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Sep 18, 2024 at 2:30 AM#40
Dr.KarenChen said:
It helps to say which part of this you are uncertain about.

This is my experience too, for whatever a second data point is worth.

9 7kim_atl_prep, sarah_TO, wendy_avl and 6 others
Reply Quote Save Share Report
167891020

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register